Search Results

Pharm Country

Curemark Announces the Addition of Christopher Varelas to the Board of Directors

Curemark, LLC announced the appointment of Chris Varelas to its Board of Directors. Mr. Varelas is a Co-founding Partner of Riverwood Capital, an investment firm focused on high-growth technology and technology-related companies.

February 1, 2024

·

3 min read

Pharm Country

JAMA Publishes Article Showing Long-Term Improvement in Autism with Curemark’s Pancreatic Replacement Therapy

Curemark today announced the publication of their long-term clinical data demonstrating disease/disorder modification in maladaptive behaviors in children as young as 3 years of age with Autism Spectrum Disorder (ASD).

December 4, 2023

·

3 min read

Pictured: A child covering his ears over a neuron

Drug Development

As Autism Cases Rise, Biopharma Springs Into Action

Several companies—including Roche, Curemark and Yamo Pharmaceuticals—are running clinical trials of treatments that aim to offset the myriad challenges of autism.

April 25, 2024

·

6 min read

·

Tyler Patchen

Business

Curemark Announces the Key Addition of Dr. William R. McIntyre as Senior Vice President of Global Regulatory Affairs

Curemark announced the key addition of Dr. William R. McIntyre to the team as the Senior Vice President of Global Regulatory Affairs, effective immediately.

September 22, 2022

·

3 min read

Business

Curemark Announces The Appointment of Afia Asamoah To The Board of Directors

Curemark, LLC announced the appointment of Afia Asamoah to its Board of Directors, effective immediately. She is currently Head of Legal for the health business unit of Google.

September 29, 2021

·

3 min read

Business

Curemark Announces The Appointment Of Leigh Morgan To The Board Of Directors

Curemark, is pleased to announce the appointment of Leigh Morgan of Seattle, WA to its Board of Directors.

October 28, 2020

·

3 min read

Business

CUREMARK Honored by Goldman Sachs for Entrepreneurship

Dr. Joan M. Fallon, CEO and Founder Among 100 Most Intriguing Entrepreneurs at 2020 Builders + Innovators Summit

October 14, 2020

·

3 min read

Drug Development

Curemark Presents at the International Society of Autism Research (INSAR) 2019 Annual Meeting

Curemark, LLC announced today that results from its Phase 3 clinical trial, the Blüm Study, were presented at the International Society of Autism Research (INSAR) Annual Meeting held in Montreal, Canada from May 1-4, 2019.

May 6, 2019

·

4 min read

Drug Development

CureMark Completes Enrollment For Its Phase III Clinical Trial For Children With Autism - The Blüm Study

September 25, 2017

·

3 min read

Drug Development

CureMark Release: Blüm Study - A Phase 3 Clinical Trial For Children With Autism

September 22, 2016

·

5 min read